Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2012-05-18 Fund Information / Fact…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Fund Information / Factsheet 2012
Fund Information / Factsheet Classification · 98% confidence The document is explicitly titled "Factsheet Q1 / 2012" and contains key financial metrics (Umsatz, EBIT, Bilanzsumme) for Q1 2012 compared to previous full years (2011, 2010, 2009). It also includes a company profile, structure overview, stock/bond information, and a financial calendar. This structure, focusing on summarized key figures for a specific interim period (Q1), aligns perfectly with the definition of a Fund Information / Factsheet (FS), which is described as a brief summary of key facts and financials. It is not a comprehensive Interim Report (IR) or Annual Report (10-K), but rather a high-level summary document.
2012-05-18 German
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the header that it is a 'Voting Rights Announcement' dated May 15, 2012. The content details notifications received pursuant to section 21 para. 1 of the WpHG (German Securities Trading Act) regarding changes in the percentage of voting rights held by various BlackRock entities, crossing specific thresholds (5% and 3%). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes and related announcements like voting rights changes.
2012-05-15 English
Deutsche Bank German & Austrian Corporate Conference
Investor Presentation Classification · 100% confidence The document is a presentation titled 'Deutsche Bank German & Austrian Corporate Conference' dated May 15, 2012. It contains financial highlights, segment updates, and forward-looking statements for Fresenius Group. Because it is a slide deck used for an investor conference, it falls under the category of an Investor Presentation. Q1 2012
2012-05-15 English
Fresenius SE & Co. KGaA: Fresenius successfully completes capital increase
Capital/Financing Update Classification · 98% confidence The document is an 'Ad-hoc' announcement dated May 11, 2012, explicitly stating that 'Fresenius successfully completes capital increase'. It details the placement of new ordinary shares, the gross proceeds, and confirms this is part of the financing for a planned acquisition. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a mere announcement of a report publication (RPA), as it contains the substantive details of the financing event itself.
2012-05-11 English
Fresenius SE & Co. KGaA: Fresenius resolves on capital increase of approx. EUR1 billion
Share Issue/Capital Change Classification · 98% confidence The document is an 'Ad-hoc' announcement dated May 10, 2012, explicitly stating that 'Fresenius resolves on capital increase of approx. EUR1 billion'. It details the resolution by the Management Board to issue 13.8 million new ordinary shares through an accelerated bookbuilt offering to finance a planned acquisition. This content directly relates to fundraising, financing activities, and changes in the capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is an announcement, the core subject is the financing action itself, not just the announcement of a report, making CAP a more specific fit than RPA or RNS.
2012-05-10 English
Q1 Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group for the 1st Quarter of 2012. It contains detailed financial statements (income statement, cash flow, balance sheet), segment reporting, and management discussion and analysis. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2012
2012-05-07 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.